Aikawa Tadao, Mori Yuichiro, Kohsaka Shun, Matsue Yuya, Kuno Toshiki, Yamaji Kyohei, Ozaki Dai, Tokano Takashi, Kozuma Ken, Minamino Tohru
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Human Health Sciences, Kyoto University, Kyoto, Japan.
J Soc Cardiovasc Angiogr Interv. 2025 May 13;4(7):103622. doi: 10.1016/j.jscai.2025.103622. eCollection 2025 Jul.
Acute coronary syndrome (ACS) is considered a relative contraindication to coronary atherectomy; however, expert consensus documents do not preclude its use for ACS. We investigated the temporal trends and hospital variability in the utilization and outcomes of coronary atherectomy among patients with ACS undergoing percutaneous coronary intervention (PCI) using data from a Japanese nationwide registry.
First, we analyzed the temporal trend in the use of rotational atherectomy (RA) and orbital atherectomy during PCI for patients with ACS between 2014 and 2022 (822,237 PCI across 1269 hospitals). Next, we assessed the outcomes of the patients who underwent RA for ACS between 2019 and 2022 (7421 PCI across 662 hospitals). The primary outcome was in-hospital mortality after PCI. We also evaluated the effects of PCI volumes and the 2020 policy change in Japan that allowed operators to perform coronary atherectomy at low PCI volume hospitals (<200 PCI/y) without on-site surgical backup on outcomes.
The overall usage rates of RA and orbital atherectomy for ACS were low, at 2.0% and 0.8%, respectively. RA for ACS was never performed at 581 hospitals (46%). After adjusting for the baseline characteristic, in-hospital mortality after RA for ACS was not significantly associated with hospital PCI volumes (odds ratio, 0.94; 95% CI, 0.65-1.36; = .73 for highest vs lowest tertiles) or the initiation of coronary atherectomy after the policy change (odds ratio, 0.99; 95% CI, 0.63-1.51; = .95).
Coronary atherectomy for ACS is infrequently performed in Japan. PCI volume and on-site surgical backup were not significantly associated with in-hospital mortality after coronary atherectomy for ACS.
急性冠状动脉综合征(ACS)被认为是冠状动脉旋切术的相对禁忌证;然而,专家共识文件并未排除其在ACS中的应用。我们利用日本全国性登记处的数据,调查了接受经皮冠状动脉介入治疗(PCI)的ACS患者中冠状动脉旋切术的使用时间趋势和医院差异及治疗结果。
首先,我们分析了2014年至2022年期间ACS患者PCI术中使用旋磨术(RA)和轨道旋切术的时间趋势(1269家医院共822237例PCI)。接下来,我们评估了2019年至2022年期间接受RA治疗的ACS患者的治疗结果(662家医院共7421例PCI)。主要结局是PCI术后住院死亡率。我们还评估了PCI手术量以及日本2020年政策变化的影响,该政策允许操作者在低PCI手术量医院(<2 PCI/年)进行冠状动脉旋切术而无需现场手术后备支持对治疗结果的影响。
ACS患者RA和轨道旋切术的总体使用率较低,分别为2.0%和0.8%。581家医院(46%)从未对ACS患者进行过RA治疗。在调整基线特征后,ACS患者RA术后住院死亡率与医院PCI手术量(比值比,0.94;95%可信区间,0.65 - 1.36;最高三分位数与最低三分位数相比P = 0.73)或政策变化后开始进行冠状动脉旋切术(比值比,0.99;95%可信区间,0.63 - 1.51;P = 0.95)均无显著相关性。
在日本,针对ACS的冠状动脉旋切术很少进行。PCI手术量和现场手术后备支持与ACS患者冠状动脉旋切术后的住院死亡率无显著相关性。